Violation Tracker Individual Record

Company: 
Insys
Current Parent Company: 
Insys Therapeutics
Penalty: 
$1,100,000
Year: 
2015
Date: 
August 5, 2015
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
kickbacks and bribery
Violation Description: 

The Oregon Attorney General reached a $1.1 million settlement with Insys, manufacturer of the schedule II opioid drug Subsys, to resolve allegations that the powerful drug approved by the Food and Drug Administration to treat cancer pain was marketed in Oregon for off-label uses such as non-cancer neck and back pain. The company was also alleged to have given improper financial incentives to doctors.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Oregon Attorney General
Civil or Criminal Case: 
civil
Facility State: 
Oregon
HQ Country of Parent: 
USA
HQ State of Parent: 
Arizona
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.